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A B S T R A C T
Pap smears of postmenopausal women are often misdiagnosed because of the difficulty in distinguishing atrophic ep-
ithelial cells groups only by morphological criteria. In this study we investigated the diagnostic application of immuno-
cytochemical staining of p16INK4a on conventional Pap smear. A total of 137 cervical specimens were enrolled in this
study, of which 77 and 60 cervical smears were taken from premenopausal and postmenopausal women, respectively.
Two cervical smears were taken simultaneously in 68 women, one for conventional cytology and the other for immuno-
staining. Additional 69 cervical smears were taken from the archive, decolorized and then used for immunostaining. In
premenopausal women 1 out of 14 (7.1%) with negative cytology, 7 out of 24 (29.2%) with low grade squamous intra-
epithelial lesion (LSIL), all 35 (100%) with high grade squamous intraepithelial lesion (HSIL) and all 4 (100%) with
squamous cell carcinoma (confirmed by histopathology) had positive staining to p16INK4a. In postmenopausal women
p16INK4a positivity was observed in 4 out of 7 (57.1%) cases of LSIL, 12 out of 14 (85.7%) cases of HSIL and all 4 out of 5
(80%) different cases of carcinoma (1 cervical adenosquamous carcinoma and 3 cervical squamous cell carcinoma in situ
confirmed by histopathology), but none of 34 smears with normal cytology. Twenty smears with normal cytology chosen
for the negative control in this study were from the group of postmenopausal women and were as expected negative for
p16INK4a immunostaining. In the group of postmenopausal women, 16 out of 60 (26.7%) cases the cytological diagnosis
was established on the basis of p16INK4a immunostaining as being HSIL. From our preliminary study on a limited num-
ber of samples, we can however conclude that p16INK4a immunostaining is a very useful tool for cytological diagnosis en-
abling to distinguish HSIL from normal, reactive or inflammatory changes.
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Introduction
It is well established that persistant infection with
oncogenic Human papillomavirus (HPV) causes preneo-
plastic and neoplastic changes of the cervical epithelium,
leading towards carcinoma, especially in middle aged
women1. In postmenopausal age, women have received
little attention concerning this problem. Improvements
in life standards and better health care have led to in-
creasing population of elderly women who come to their
regular gynaecological exam and their Papanicolaou (Pap)
smears2–3. In spite of the fact that there is almost 20% of
women infected with HPV4, only a few of them develop
preneoplastic lesion, and even fewer develop cancer.
Smith and al.5 found that 16% of persistent HPV infec-
tions exist in the elderly group of women, suggesting that
one can predict development of a preneoplastic lesion
that can progress toward cancer. However, problems in
diagnosis such as aging-related changes, reparative chan-
ges and interpretation difficulties may lead towards an
incorrect diagnosis. Pap smears of postmenopausal wo-
men are often misdiagnosed because of the difficulty in
distinguishing atrophic epithelial cell groups only by the
morphological criteria. Those criteria are more viable
when premenopausal women are concerned, referred to
better oestrogen effect, hence better maturation. In this
study we investigated whether immunocytochemical sta-
ining of p16INK4a, performed on conventional Pap smear
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could be of any diagnostic help in solving this dilemma.
Thus, we performed p16INK4a immunostaining on speci-
mens taken from premenopausal and postmenopausal
women in order to make an accurate diagnosis in those
cases, which were impossible for us to distinguish on the
basis of cytomorphological criteria, i.e. to distinguish a
high grade cervical lesion from atrophy or reactive chan-
ges.
Examinees, Materials and the Methods
We analysed 137 cervical smears, which consisted in
69 archival Pap slides and 68 cervical specimens collected
from women who attended our clinic in 2006 for their
regular check-up. They were divided into two age groups.
Seventy-seven premenopausal women were in group I
(median age 34.5) and 60 postmenopausal women (me-
dian age 63) in group II, of which 20 women with normal
cervical smears were used as a control group.
Two simultaneous cervical smears were taken by a
cytobrush and a wooden spatula, one for conventional cy-
tology and the other for immunostaining. Archival Pap
slides were decolorized in 0.5% HCl, rinsed with distilled
water and then immunocytochemically stained with
CINtec™ p16INK4a Kit (DAKOCytomation, Denmark) ac-
cording to the manufacturer instructions. There were no
differences in staining reaction or intensity of reaction
between decolorized and freshly taken smears. Accord-
ing to DAKO instructions at least 1% of cells should be
stained for the reaction to be considered positive. Cells
are regarded as stained if brownish-like granules were
found in nuclei and/or in a cytoplasm.
Pap smears were classified by the »Bethesda system«6
into a normal epithelium, low (LSIL) and high grade
intraepithelial cervical lesion (HSIL) and squamous cell
carcinoma (SCC). Among postmenopausal women, there
was one case of recurrent adenosquamous carcinoma and
metastatic transitional cell carcinoma. In 16 postme-
nopausal women we could not diagnose based on the
morphological criteria; in those women diagnosis was es-
tablished after the p16INK4a immunostaining.
In total, fifty-five women underwent colposcopy and
biopsy, and a consequent cold knife conisation or hyster-
ectomy was performed; in each case histological verifica-
tion was made. Unfortunately, the patient with meta-
static transitional cell carcinoma died.
The distribution of positivity rate versus diagnosis
was analyzed with the standard Chi–square (c2) test. The
statistical significant differences was set at p<0.025.
Results
The distribution of cytological diagnoses and p16INK4a
immunostaining in premenopausal women is as follows:
18.2% (14/77), 31.2% (24/77), 45.5% (35/77) and 5.2%
(4/77) women had a negative cytology, LSIL, HSIL, SCC,
respectively (Table 1). P16INK4a immunostaining was ob-
served in 7.1% (1/14), 29.2% (7/24) and 100% (35/35 and
4/4) of premenopausal women with negative cytology,
LSIL, HSIL and SCC, respectively. The observed frequ-
encies were significantly different (c2=52.24, p<0.0001).
The positive p16INK4a immunostaining of one of the 4
SCC later histologically confirmed, and of normal me-
taplastic cells is shown in Figure 1 and 2. In this age
group we succeed to diagnose all smears according to via-
ble morphological signs and well established criteria for
every grade of intraepithelial lesion.
The distribution of cytological diagnoses and p16INK4a
immunostaining in postmenopausal women is as follows:
52.3% (34/60), 10.8% (7/60), 21.5% (14/60) and 7.7%
(5/60) women had a negative cytology, LSIL, HSIL, SCC,
respectively (Table 2). P16INK4a immunostaining was ob-
served in 57.1% (4/7), 85.7% (12/14) and 80% (4/5) of
postmenopausal women with LSIL, HSIL and SCC, re-
spectively, while none with those with normal cytology.
The observed frequencies were significantlly different
(c2=40.97, p<0.0001).
In 16 postmenopausal women we had difficulties for
classifying a certain cell groups as neoplastic because of
their resemblance to mucosal atrophy or because of the
presence of strong degenerative, inflammatory or reac-
tive changes. In 8 women, after p16INK4a immunostaining
we were able to distinguish HSIL from reactive changes
(Figure 3). Among these women one case of previously
diagnosed adenosquamous carcinoma, was p16INK4a posi-
tive, indicating the possibility of recurrent carcinoma.
Discussion
In spite of good screening methods based on Pap
smear and well organized screening programmes in
many countries, women all around the world continue to
develop cervical disease. The incidence rate of cervical
cancer in developing countries is increasing due to the
aging population, while in Western Europe first peak is
between 30 and 40 years of age and the second peak oc-
curs around 60 years of age7. Genital infection with
oncogenic or high-risk (hr) HPV is established as one of
the main events in pathogenesis of cervical and other
genital tumours1. After the first contact with the virus,
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TABLE 1
P16INK4a FINDINGS ACCORDING TO DIAGNOSIS
OF PREMENOPAUSAL WOMEN
p16INK4a
N (%) of cytological diagnosis
Normal LSIL HSIL
Carci-
noma
Total
Negative 13 (92.9) 17 (70.8) 0 0 30 (39)
Positive 1 (7.1) 7 (29.2) 35 (100) 4 (100) 44 (61)
Total 14 (18.2) 24 (31.2) 35 (45.5) 4 (5.2) 77 (100)
LSIL – low grade squamous intraepithelial lesion, HSIL – high
grade squamous intraepithelial lesion, *cervical squamous cell
carcinoma in situ confirmed by histopathology, c2 = 52.24, p <
0.0001
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viral replication is limited to superficial layers of the cer-
vical epithelium that represents the acute, transitory
phase. If viral E6 and E7 oncogene products are over-ex-
pressed in a basal or parabasal layers, they will interfere
with the regulation of the host cell cycle, inducing ge-
netic instability. The probability of progression of cervi-
cal precancerogenic lesions is considered greater with the
longer persistence of papillomavirus infection. Almost
100% of all cervical cancers can be attributed to certain
hrHPV types8. The highest proportion of cervical squa-
mous cancers is associated with HPV type 16, followed by
type 18 which is more common in adenocarcinomas, than
HPV types 31, 33, 45, 52, 58 and others1,7.
There are lots of regulating proteins involved in the
cell cycle control. One of them, p16INK4a, has been shown
to be over-expressed after the cell has been infected by
hrHPV types. Expression of the viral E7 oncogene leads
to functional inactivation of tumour suppressor retino-
blastoma protein (pRB), which in turn, results in strong
over-expression of the cyclin-dependent kinase inhibitor
p16INK4a. This indicates that an active expression of the
viral E7 oncogene is present in dysplastic cells4.
There are a lot of data about HPV prevalence in youn-
ger women, but not much about elderly population. Smith
et al.5 showed that, opposite to a common belief, the prev-
alence rate of HPV in postmenopausal women was al-
most as high as in younger women and the association
between hrHPV and consecutive abnormal Pap smear
was 36%. Bosch and Harper7 on the other hand summa-
rised the results from cohort studies and found that
hrHPV infection persisted in 50% cases. Bruner and
Davey9 had similar results in their group of women aged
60 years and over in contrast with 20% of hrHPV positive
infection in younger groups (40 and 50 year old women).
That leads towards conclusion of Massad et al.10 that
older women more frequently have a higher abnormality
grade, while younger women had more lesions connected
with transient infection.
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Fig 3. p16INK4a staining of high grade squamous intraepithelial
lesion (HSIL) found in a smear of a postmenopausal woman
Fig 2. p16INK4a staining of normal metaplastic cells found in a
smear of a premenopausal woman
TABLE 2
P16INK4a FINDINGS ACCORDING TO DIAGNOSIS OF
POSTMENOPAUSAL WOMEN
p16INK4a
N (%) of cytological diagnosis
Normal LSIL HSIL Carcinoma Total
Negative 34 (100)* 3 (42.9) 2 (14.3) 1** (20.0) 40 (66.7)
Positive 0 4 (57.1) 12 (85.7) 4*** (80.0) 20 (33.3)
Total 34 (52.3) 7 (10.8) 14 (21.5) 5 (7.7) 60 (100)
LSIL – low grade squamous intraepithelial lesion, HSIL – high
grade squamous intraepithelial lesion, *include 20 women as
control group, **transitional cell carcinoma confirmed by his-
topathology, ***1 case of cervical adenosquamous carcinoma and
3 cases of cervical squamous cell carcinoma in situ confirmed by
histopathology, c2=40.97, p<0.0001
Fig 1. p16INK4a staining of malignant squamous cells found in a
smear of a premenopausal woman
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In our study, following »Bethesda recommendations«
we classified lesions as normal including inflammatory
and reactive changes, as LSIL presented with or without
koilocytotic changes, as HSIL and as carcinoma. Among
premenopausal women with normal cervical smears p16-
-positive metaplastic cells were noted in one patient. It is
known that some metaplastic and endocervical normal
cells could be positively stained due to unfinished differ-
entiation of the cells. Staining intensities of the normal,
metaplastic cell are weaker than in dysplastic10,12, and
staining was observed only in the cytoplasm, while the
nucleus showed no staining reaction. After p16INK4a im-
munostaining, most (70.8%) of dysplastic cells in LSIL
were stained negative in a group of premenopausal wo-
men. There were only 7 (29.2%) LSIL smears with a
stained reaction in the nucleus and cytoplasm of the cells
(Figure 1). All of these premenopausal women with HSIL
were hrHPV positive (data not shown). Our results
showed p16INK4a overall positivity of 61% that is similar
to the results of Bose et al.13, although higher percentage
up to 78% were reported previously14,15. We agree with
the statement of Bose that p16INK4a does not have a role
in the diagnosis of LSIL but it might be useful for con-
firming the diagnosis of HSIL since our study showed
positive staining in all HSIL. The role of p16INK4a as a
predictive and prognostic factor is to be confirmed by ad-
ditional large scale studies.
Correct cytological diagnosis of cervical abnormalities
in older women is a much greater problem because of the
morphological similarities between atrophic epithelial
cells and cells from high-grade squamous lesion. There-
fore one should keep in mind several cytomorphologic
findings such as: clean smear background, maturation
index, nuclear/cytoplasmatic ratio, presence of hyper-
chromasia and then incorporate that in physiologic and
pathologic changes of women’s genital tract. Saad et al.16
divided impact factor analysis to individual (degree of
cell maturation, patient age, and smear background) and
the other ones that dramatically influenced accurate di-
agnosis. The following factors were suggested: nuclear
membrane features, hyperchromasia with nuclear/cyto-
plasmatic ratio favouring nucleus and abnormal single
cell arrangement. These cytomorphologic findings lead
us to an »uncertain« cytological diagnosis in postmeno-
pausal smears with profound inflammatory or degenera-
tive changes. By performing p16INK4a immunostaining, in
case that it is positive in the nucleus and cytoplasm, we
will be able to classify some of these »uncertain« lesions
as likely to be HSIL, which could be further confirmed by
histology. In cytologically negative smears of postmeno-
pausal women, p16INK4a staining was negative as well.
Conclusion
From our preliminary study on a limited number of
samples, it appears that although p16INK4a is not helpful
in the diagnosis of LSIL in younger women, in post-
menopausal women it may be useful for confirming cer-
vical lesion even if cytological diagnosis was mild dys-
plasia. To avoid »uncertain« diagnosis when the rate of
possible false-negative diagnoses as well as false-positive
cytology is high, we think that the use of p16INK4a stain-
ing would be helpful for identification of adequate diag-
nosis.
For elderly women with squamous atypia an oestro-
gen treatment is often suggested, maturation effect can
make an abnormal cell more viable and abnormal reac-
tive changes disappear. That involves repeated patient’s
discomfort of physical exam as well as a certain dose of
stress. To minimize that we suggest taking two simulta-
neous smears during Pap sampling; it will allow to per-
form normal Pap and p16INK4a immunostaining. In this
way, we will be able to distinguish more accurately nor-
mal, non-specific reactive or inflammatory changes from
neoplastic changes in postmenopausal women Further-
more, p16INK4a immunostaining would be useful in a rou-
tine laboratory practice for analysis and follow-up of abnor-
mal cervical smears in general. Further population-based
studies will be necessary to analyse predictive value of
p16INK4a protein in cervical smears in both groups of
women.
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PROCJENA P16INK4a U LEZIJAMA VRATA MATERNICE KOD @ENA
U GENERATIVNOJ DOBI I POSTMENOPAUZI
S A @ E T A K
^este su pogre{ne citolo{ke dijagnoze cervikalnih razmaza `ena u postmenopauzi zbog sli~nosti u morfolo{kom
izgledu stanica dubljih slojeva epitela i neoplasti~no promijenjenih stanica. U na{oj studiji istra`ili smo primjenu imu-
nocitokemijskog bojanja sa p16INK4a na cervikalnim razmazima u svrhu rje{avanja tog problema. Imunocitokemijski
smo obojali uzorke 77 `ena u generativnoj dobi i 60 uzoraka `ena u postmenopauzi. Kontrolnu skupinu su sa~injavali
20 urednih citolo{kih razmaza bez izra`enih upalnih ili degenerativnih promjena iz skupine `ena u postmenopauzi.
Kod 68 pacijentica prilikom uzimanja uzoraka u~inili smo 2 razmaza: jedan za citolo{ku analizu a drugi za imuno-
citokemijsko bojanje. [ezdesetdevet predhodno uzetih uzoraka smo odbojali i pripremili za imunoreakciju. Kod `ena
generativne dobi 14 pacijentica je imalo uredan Papa-test i opa`en je p16INK4a pozitivitet kod jednog uzorka (7,1%); 24
uzoraka je ocijenjeno kao SIL (skvamozna intraepitelna lezija) niskog stupnja i me|u njima je bilo 7 (29,2%) p16INK4a
pozitivno obojenih uzoraka. Svih 39 uzoraka SIL visokog stupnja, od kojih 4 karcinoma plo~astih stanica in situ nak-
nadno histolo{ki utvr|enih, pozitivno se obojilo. Pozitivitet p16INK4a kod razmaza starijih `ena je rastao u slijede}em
nizu: 0%, 57,1%, 85,7% i 80% kod 34 urednih razmaza, 4 razmaza niskog i 12 visokog SIL te 4 karcinoma naknadno
histolo{ki utvr|enih (1 adenokarcinom, 3 karcinoma plo~astih stanica in situ). U skupini od 16 pacijentica, to~na cito-
lo{ka dijagnoza SIL-a visokog stupnja postavljena je tek nakon imunocitokemijske reakcije. Na temelju na{eg preli-
minarnog istra`ivanja namalom broju uzoraka, mo`emo zaklju~iti da uklju~ivanje p16INK4a imunocitokemijskog bojanja u
redovitu laboratorijsku praksu mo`e pomo}i u razlikovanju reaktivnih ili degenerativnih promjena od neoplasti~nih
lezija cervikalnog epitela.
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